A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
Recruiting · NCT05813678 · Registry updated 2026-03-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace) | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, nervous system disorder, phenylketonuria | Recruiting | Not stated | 2026-03-25 | NCT05813678 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BioMarin Pharmaceutical | 32 |
26 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.